INVOKANA 300MG 30 tablets
14.580 د.ك
Used To Control Blood Glucose Level
Out of stock
Notify me when item is back in stock.
Invokana 300mg Tablets is used with Diet and excersice alone or in combination with other anti diabetic drugs to control type 2 diabetes mellitus , and avoid serious complications of diabetes. also for people with heart and/or kidney diseases it helps reduce risks of these diseases.
Based on 0 reviews
|
|
0% |
|
|
0% |
|
|
0% |
|
|
0% |
|
|
0% |
Only logged in customers who have purchased this product may leave a review.
-
ZARTAUX BOTEX 30 ML CREAM 29.000 د.ك
-
ISIS TEEN DERM HYDRA 7.800 د.ك
-
EUCERIN SUN CREAM 50+KIT 8.900 د.ك
Related Products
Used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery.
Out of stock
reduce high blood sugar levels in Type 2 diabetes mellitus (non-insulin-dependent diabetes mellitus – NIDDM).
Out of stock
Effective in the treatment of dermal infections caused by bacteria, fungi, yeasts, viruses and protozoa.
Indicated for the treatment of herpes simplex, herpes zoster.
Treatment or prevention of infection in minor cuts and abrasions
Out of stock
Treatment of severe itching or severe sensitivity and skin rashes
Out of stock
Betadine Dry Powder Spray contains an active ingredient, Povidone-iodine 2.5% w/w for treatment and prevention of infections in wounds.
It has a broad microbicidal spectrum.
It is rapidly effective in killing most organisms in vitro.
Out of stock
treatment of mild to moderately severe Alzheimer’s dementia.
Out of stock
Rehydration treatment in case of diarrhea and overheating.
Out of stock
Betadine Antiseptic rapidly kills all bacteria and fungi commonly responsible for wound and skin infections
Out of stock
It kills most microorganisms and is termed as a broad spectrum microbicidal.
● effective against bacteria, viruses, fungi, spores, and protozoa
● first aid and better personal hygiene
Out of stock
Treatment for patients with moderate to severe Alzheimer’s disease
Out of stock
Reviews
There are no reviews yet.